Amneal announces 26 generic new product launches in 2022 and first injection large volume bag approval

Bridgewater, n.j.--( business wire )--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) today announced that the company has successfully launched 26 new generic products in 2022. in the fourth quarter of 2022, the company launched 8 new generic products, including clindamycin phosphate gel 1%, ipratropium bromide nasal sprays, and prednisolone sodium phosphate oral solution.
AMRX Ratings Summary
AMRX Quant Ranking